(02-07) 10:34 PST , (AP) -- STRIKE TWO: A second study shows Merck's experimental anti-clotting drug vorapaxar increased risk of dangerous internal bleeding, including inside the skull. The study, called TRA-2P, did...
By The Associated Press, San Francisco Chronicle: Business
Tue, 02/07/2012 - 11:34am
(02-07) 10:34 PST , (AP) -- STRIKE TWO: A second study shows Merck's experimental anti-clotting drug vorapaxar increased risk of dangerous internal bleeding, including inside the skull. The study, called TRA-2P, did...